EP1511490A4
Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
55 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO2004078163A2 | Cites | World Intellectual Property Organization (WIPO) | E | Search report | 1-19 |
| WO2004078163A | Cites | World Intellectual Property Organization (WIPO) | – | – | – |
| RASENACK NORBERT ET AL: "Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs.", December 2002, PHARMACEUTICAL RESEARCH (DORDRECHT), VOL. 19, NR. 12, PAGE(S) 1894-1900, ISSN: 0724-8741 | Non-patent | – | – | Examiner | – |
| HEINRICH STAHL P ED - WERMUTH C G: "The Practice of Medicinal Chemistry; 35 Preparation of water-soluble compounds through salt formation", 1 January 2003, THE PRACTICE OF MEDICINAL CHEMISTRY, ELSEVIER, NL, PAGE(S) 601 - 615, ISBN: 978-0-12-744481-9, XP002566271 | Non-patent | – | – | Examiner | – |
188 members in 20 offices
Priority claims11
| Document | Office | Kind | Date |
|---|---|---|---|
| 384152P | United States of America | – | |
| 38415202 | United States of America | P | |
| 439282P | United States of America | – | |
| 43928203 | United States of America | P | |
| 444315P | United States of America | – | |
| 44431503 | United States of America | P | |
| 463962P | United States of America | – | |
| 46396203 | United States of America | P | |
| 449307 | United States of America | – | |
| 0317184 | United States of America | W | |
| 44930703 | United States of America | A |
Members188
| Document | Office | Kind | |
|---|---|---|---|
| US6559293B1 | United States of America | B1 | |
| CA2476422A1 | Canada | A1 | |
| WO03070738A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003166581A1 | United States of America | A1 | |
| AU2003211021A1 | Australia | A1 | |
| CA2477923A1 | Canada | A1 | |
| WO03074474A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003213719A1 | Australia | A1 | |
| AU2003213719A8 | Australia | A8 | |
| WO03070738A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003224006A1 | United States of America | A1 | |
| WO03101392A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO03074474A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2003243354A1 | Australia | A1 | |
| AU2003243354A8 | Australia | A8 | |
| CA2489984A1 | Canada | A1 | |
| WO2004000284A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003243699A1 | Australia | A1 | |
| US2004019211A1 | United States of America | A1 | |
| US6699840B2 | United States of America | B2 | |
| US2004053853A1 | United States of America | A1 | |
| WO2004026235A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003267231A1 | Australia | A1 | |
| AU2003267231A8 | Australia | A8 | |
| WO03101392A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004047752A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003295846A1 | Australia | A1 | |
| AU2003295846A8 | Australia | A8 | |
| CA2511881A1 | Canada | A1 | |
| WO2004060347A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004061433A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003300452A1 | Australia | A1 | |
| AU2003300452A8 | Australia | A8 | |
| AU2003303591A1 | Australia | A1 | |
| WO2004063152A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004026235A3 | World Intellectual Property Organization (WIPO) | A3 | |
| NO20043819L | Norway | L | |
| CA2513746A1 | Canada | A1 | |
| CA2514733A1 | Canada | A1 | |
| WO2004078161A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2004078163A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004047752A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2003272270A1 | Australia | A1 | |
| AU2003272270A8 | Australia | A8 | |
| BR0305421A | Brazil | A | |
| WO2004089313A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004060347A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2004063152A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1485388A2 | European Patent Office (EPO) | A2 | |
| BR0307919A | Brazil | A | |
| BR0307919A | Brazil | A | |
| KR20050002826A | Republic of Korea | A | |
| EP1494998A2 | European Patent Office (EPO) | A2 | |
| WO2004078163A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005025791A1 | United States of America | A1 | |
| EP1511490A2 | European Patent Office (EPO) | A2 | |
| AU2004270238A1 | Australia | A1 | |
| CA2534664A1 | Canada | A1 | |
| WO2005023198A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1515703A1 | European Patent Office (EPO) | A1 | |
| US2005070551A1 | United States of America | A1 | |
| RU2004127580A | Russian Federation | A | |
| MXPA05000232A | Mexico | A | |
| HRP20040847A2 | Croatia | A2 | |
| JP2005519112A | Japan | A | |
| WO2005023198A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN1646538A | China | A | |
| US2005169982A1 | United States of America | A1 | |
| JP2005524645A | Japan | A | |
| AU2005212229A1 | Australia | A1 | |
| CA2556106A1 | Canada | A1 | |
| WO2005077894A1 | World Intellectual Property Organization (WIPO) | A1 | |
| CN1668283A | China | A | |
| EP1579198A1 | European Patent Office (EPO) | A1 | |
| WO2005092884A1 | World Intellectual Property Organization (WIPO) | A1 | |
| MXPA04007968A | Mexico | A | |
| MXPA04007968A | Mexico | A | |
| JP2005535602A | Japan | A | |
| WO2004089313A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2005118577A1 | World Intellectual Property Organization (WIPO) | A1 | |
| IL163549A0 | Israel | A0 | |
| IL163846A0 | Israel | A0 | |
| EP1608339A1 | European Patent Office (EPO) | A1 | |
| ZA200407377B | South Africa | B | |
| JP2006500377A | Japan | A | |
| IL165383A0 | Israel | A0 | |
| EP1631260A2 | European Patent Office (EPO) | A2 | |
| US2006052432A1 | United States of America | A1 | |
| HK1080717A1 | Hong Kong, China | A1 | |
| NO20060669L | Norway | L | |
| MXPA06002507A | Mexico | A | |
| EP1670753A2 | European Patent Office (EPO) | A2 | |
| US2006134198A1 | United States of America | A1 | |
| IL173575A0 | Israel | A0 | |
| US2006148877A1 | United States of America | A1 | |
| HK1083770A | Hong Kong, China | A | |
| HK1083770A1 | Hong Kong, China | A1 | |
| US7078526B2 | United States of America | B2 | |
| JP2006517527A | Japan | A | |
| US2006223794A1 | United States of America | A1 |
Showing 100 of 188
9 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| First examination report despatched17Q | 17Q | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Request for extension of the european patent (deleted)DAX | DAX | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1511490
- Application
- 37563210
Titles3
- German
- NEUE KRISTALLINE CONAZOL-FORMEN UND VERWANDTE PROZESSE, PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND VERFAHREN
- English
- NOVEL CONAZOLE CRYSTALLINE FORMS AND RELATED PROCESSES, PHARMACEUTICAL COMPOSITIONS AND METHODS
- French
- NOUVELLES FORMES CRISTALLINES DE CONAZOLE ET PROCEDES ASSOCIES, COMPOSITIONS PHARMACEUTIQUES ET METHODES
Classification
- CPC, 9
- A61K9/0014
- A61K9/1652
- A61K47/10
- A61K47/32
- C07D405/14
- A61P17/00
- A61P25/00
- A61P31/04
- A61P31/10
- IPC, 17
- A61K9 00
- A61K9 16
- A61K9 64
- A61K31 496
- A61K47 10
- A61K47 32
- A61P17 00
- A61P25 00
- A61P31 04
- A61P31 10
- B01D9 02
- C07C57 15
- C07C59 255
- C07C309 29
- C07D233 74
- C07D405 14
- G01N33 15
Designated states27
- Contracting states, 27
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Italy
- Liechtenstein
- Luxembourg
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Romania
- Sweden
and 3 moreShow fewer
- Slovenia
- Slovakia
- Türkiye
